RECOMBINANT HUMAN PAPILLOMAVIRUS (HPV) QUADRIVALENT VACCINE

In June 2006, the quadrivalent HPV vaccine types 6,11,16,18 (GARDASILTM, manufactured by Merck and Co., Inc., Whitehouse Station, New Jersey) was licensed for use among females aged 9-26 years.

It aims to prevent HPV-type–related cervical cancer, cervical cancer precursors, vaginal and vulvar cancer precursors, and anogenital warts. Efficacy studies are on-going in men.

This vaccine is not recommended for use during pregnancy. Consult your health care professional for more details.

Minor symptoms may occur. If any of symptoms persist or worsen, tell your health care professional promptly.

Precautions

This product may contain inactive ingredients, which can cause allergic reactions or other problems.

 

Interactions

Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your health care professional. Do not starts, stop, or change the dosage of any medicines without your doctor’s approval.

Available brand:

  • Gardasil

Related Articles

ULTRAVIST

UsesWarningsSide EffectsPrecautionsOverdose & BrandsUses Ultravist is used in the following conditions: Radiographic Imaging: Iopromide injection is utilized to enhance the [...]

ULTRAMOX

UsesWarningsSide EffectsPrecautionsOverdose & BrandsUses Ultramox is used in the following conditions: Respiratory Infections: Amoxicillin is often used to treat respiratory [...]

ULTRALIV

UsesWarningsSide EffectsPrecautionsOverdose & BrandsUses Ultraliv is used in the following conditions: Carnitine Orotate: Carnitine orotate is a combination of L-carnitine [...]